Search clinical trials for: ACP-196 (acalabrutinib)
Total 8069 results
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Chronic Myeloid Leukemia (CML)United States
-
University Hospital, GhentCompletedOrthodontic Appliance Complication | White Spot LesionBelgium
-
Tufts Medical CenterNational Institute on Aging (NIA)CompletedPalliative Care | Advance Care Planning | Alzheimer's Disease and Related Dementias | Doctor-patient Communication | Video Decision AidsUnited States
-
Cairo UniversityUnknown
-
Bispebjerg HospitalCompleted
-
Imperial College LondonDuska Scientific Co.CompletedSmoking | Asthma | COPDUnited Kingdom
-
University of ZagrebCroatian Institute of Health InsuranceCompletedJoint InstabilityCroatia
-
Brii Biosciences LimitedTSB Therapeutics (Beijing) CO.LTDCompleted
-
LanZhou UniversityUnknownMeibomian Gland Dysfunction | Sjögren's SyndromeChina
-
Dana-Farber Cancer InstituteCompleted
-
University of ZurichCompletedPalliative Patients | Surrogate Decision MakerSwitzerland
-
National Center for Tumor Diseases, HeidelbergAstraZeneca; German Cancer Research Center; PharmaMarCompletedCancers With DNA Repair-DeficiencyGermany
-
Ascendis Pharma Endocrinology Division A/SActive, not recruitingEndocrine System Diseases | Adult Growth Hormone Deficiency | Hormone DeficiencyUnited States, Armenia, Georgia, Greece, Ukraine, Australia, Canada, France, Israel, Italy, Japan, Malaysia, Poland, Romania, Serbia, Slovakia, Spain, Turkey, United Kingdom, Germany, Korea, Republic of
-
The University of Hong KongRecruitingAdvanced Care PlanningHong Kong
-
M.D. Anderson Cancer CenterRecruitingChronic Lymphocytic LeukemiaUnited States
-
ACADIA Pharmaceuticals Inc.Recruiting
-
Acerta Pharma BVCompletedA Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196Healthy ParticipantsUnited States
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 Diabetes Mellitus | Eating DisordersUnited States
-
University College, LondonAstraZenecaNot yet recruitingMantle Cell Lymphoma
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
End-of-Life Research GroupCompletedElderly Care | Advance Care Planning | Nursing HomeBelgium
-
Columbia Orthopaedic Group, LLPTerminated
-
Mitsubishi Tanabe Pharma CorporationTerminatedChronic Kidney Disease | Hyperphosphatemia | DialysisFrance, Poland, Spain, Serbia, South Africa, Czech Republic, Germany, Macedonia, The Former Yugoslav Republic of, Italy, United Kingdom
-
Hasselt UniversityJessa Hospital; University Hospital, Ghent; University GhentRecruitingNon-small Cell Lung Cancer | Non-small Cell CarcinomaBelgium
-
Massachusetts General HospitalNational Institute on Aging (NIA); University of California, DavisRecruitingEmergenciesUnited States
-
Dongzhimen Hospital, BeijingCompletedMild Cognitive Impairment | Herbal Medicine AllergyChina
-
University of PennsylvaniaTerminatedChronic Kidney Diseases | Advance Care Planning | Conservative Kidney ManagementUnited States
-
Hong Kong Metropolitan UniversityChinese University of Hong Kong; The British Council in Hong KongCompletedMild Cognitive Impairment | Dementia MildHong Kong
-
Mitsubishi Tanabe Pharma CorporationCompletedChronic Kidney Disease | Hyperphosphatemia | DialysisUnited States, Canada
-
Maureen LyonJohns Hopkins University; University of Miami; St. Jude Children's Research Hospital and other collaboratorsCompleted
-
Ascendis Pharma A/SCompletedAdult Growth Hormone DeficiencySweden, Denmark, Germany, Italy
-
Acerta Pharma BVCompletedRheumatoid ArthritisUnited States
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang... and other collaboratorsNot yet recruitingPrimary Central Nervous System Lymphoma (PCNSL)
-
Johns Hopkins UniversityTerminated
-
AstraZenecaNot yet recruitingDiffuse Large B-Cell Lymphoma
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
Vanderbilt UniversityNot yet recruitingAdvance Care Planning
-
Liverpool University Hospitals NHS Foundation TrustUniversity of LiverpoolCompleted
-
Chang Gung UniversityCompletedEnd Stage CancerTaiwan
-
MedImmune LLCNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Disease | AtherosclerosisUnited States
-
Lawson Health Research InstituteUnknown
-
McMaster UniversityArthrex, Inc.CompletedRotator Cuff TearCanada
-
Mitsubishi Tanabe Pharma CorporationCompletedDyslipidemia | Chronic Kidney Disease | Hyperphosphatemia | DialysisPoland, Ukraine, Serbia, Russian Federation, Hungary, Malaysia, Italy, Macedonia, The Former Yugoslav Republic of
-
iOMEDICO AGAstraZenecaRecruiting
-
SCRI Development Innovations, LLCAcerta Pharma, LLCCompletedMantle Cell LymphomaUnited States
-
Cairo UniversityUnknown
-
University of California, San FranciscoNational Institute on Aging (NIA); University of Minnesota; University of California...Not yet recruiting
-
Yosuke UchitomiRecruitingAdvanced Cancer | Recurrent Cancer | End of Life CareJapan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast Cancer | Hot Flashes | Unspecified Adult Solid Tumor, Protocol Specific | Menopausal SymptomsUnited States
-
Shin MineishiMilton S. Hershey Medical CenterWithdrawn